Aptamers: Potential Diagnostic and Therapeutic Agents for Blood Diseases

Aljohani MM, Cialla-May D, Popp J, Chinnappan R, Al-Kattan K, Zourob M (2022)


Publication Type: Journal article

Publication year: 2022

Journal

Book Volume: 27

Article Number: 383

Journal Issue: 2

DOI: 10.3390/molecules27020383

Abstract

Aptamers are RNA/DNA oligonucleotide molecules that specifically bind to a targeted complementary molecule. As potential recognition elements with promising diagnostic and therapeutic applications, aptamers, such as monoclonal antibodies, could provide many treatment and diagnostic options for blood diseases. Aptamers present several superior features over antibodies, including a simple in vitro selection and production, ease of modification and conjugation, high stability, and low immunogenicity. Emerging as promising alternatives to antibodies, aptamers could overcome the present limitations of monoclonal antibody therapy to provide novel diagnostic, therapeutic, and preventive treatments for blood diseases. Researchers in several biomedical areas, such as biomarker detection, diagnosis, imaging, and targeted therapy, have widely investigated aptamers, and several aptamers have been developed over the past two decades. One of these is the pegaptanib sodium injection, an aptamer-based therapeutic that functions as an anti-angiogenic medicine, and it is the first aptamer approved by the U.S. Food and Drug Administration (FDA) for therapeutic use. Several other aptamers are now in clinical trials. In this review, we highlight the current state of aptamers in the clinical trial program and introduce some promising aptamers currently in pre-clinical development for blood diseases.

Involved external institutions

How to cite

APA:

Aljohani, M.M., Cialla-May, D., Popp, J., Chinnappan, R., Al-Kattan, K., & Zourob, M. (2022). Aptamers: Potential Diagnostic and Therapeutic Agents for Blood Diseases. Molecules, 27(2). https://doi.org/10.3390/molecules27020383

MLA:

Aljohani, Maher M., et al. "Aptamers: Potential Diagnostic and Therapeutic Agents for Blood Diseases." Molecules 27.2 (2022).

BibTeX: Download